• Home

  • About Us

    • Company Profile

    • Development Process

    • Strength

    • Enterprise Culture

  • Products

    • Listed Products

    • Linked API

    • Pipeline

  • Custom Services

    • Process Transfer

    • Process Validation and Registration Declaration

    • Analysis and Testing

    • API Production

  • Blog

    • Company News

    • EHS Information

    • Industry News

  • Join us

    • Recruitment Posts

    • Employee Benefits

    • Employee Activities

  • Contact Us

确认
Blog

Blog

Company News

EHS Information

Industry News

Introduction to the major revisions and additions in the 2025 edition of the Chinese Pharmacopoeia, Part I


Release time:

2025-05-08

Introduction to the Major Additions and Revisions in Volume I of the 2025 Edition of the Chinese Pharmacopoeia

Attachment: Introduction to the Major Additions and Revisions in Volume I of the 2025 Edition of the Chinese Pharmacopoeia.pdf   

Latest News

Implementation Regulations of the Pharmaceutical Administration Law of the People's Republic of China

2025-06-04

Pharmacopoeia of the People's Republic of China, 2025 Edition

2025-06-03

Policy Interpretation of the Announcement by the National Medical Products Administration on Further Improving the Issuance of Drug Production Licenses

2025-05-09

Introduction to the major revisions and additions in the 2025 edition of the Chinese Pharmacopoeia, Part I

2025-05-08

Share

Return to List

WhatsApp

5

WhatsApp

86020-8985 8964

E-mial

8

E-mial

pvreport@bio-current.com

Tel

9

Tel

86020-8985 8964


R & D Center

Address: Room 803, Building B3, Science and Technology Enterprise Accelerator, No.11 Kaiyuan Avenue, Huangpu District, Guangzhou

Telephone:020-8985 8964

Production Base

Address: No.80, Spring Equinox Road, Huangpu District, Guangzhou

Telephone:020-8328 9091

Adverse Drug Reaction/Event Feedback E-mail:pvreport@bio-current.com

er

   WeChat 

  • Home

  • About Us

    • Company Profile

    • Development Process

    • Strength

    • Enterprise Culture

  • Products

    • Listed Products

    • Linked API

    • Pipeline

  • Custom Services

    • Process Transfer

    • Process Validation and Registration Declaration

    • Analysis and Testing

    • API Production

  • Blog

    • Company News

    • EHS Information

    • Industry News

  • Join us

    • Recruitment Posts

    • Employee Benefits

    • Employee Activities

  • Contact Us

Copyright©2024 All Rights Reserved of Guangzhou Keruite Pharmaceutical Co., Ltd.

www.300.cn  SEO

Business License